Reporting on the outbreak of severe acute respiratory syndrome (SARS) is shooting at a moving target; what follows can only be a snapshot of how things looked at the end of May, when this issue of Contemporary Pediatrics went to press.
Pegtarazimod data confirms inflammation biomarkers in hypoxic ischemic encephalopathy infants
In addition, data presented at PAS revealed a predictable pharmacokinetic profile in the newborn population, consistent with adult humans.
Food Insecurity and the Dangers of Infant Formula Dilution
Antibiotic use before age 2 linked to higher childhood BMI
Early antibiotic use before age 2 is linked to higher childhood obesity risk, with timing playing a key role in long-term weight outcomes.
Demystifying Infant Formula
FDA announces measures to phase out petroleum-based food dyes
One step will be a partnership with the National Institutes of Health to research how food additives impact children's health.
PNP perspective: Nasal epinephrine spray approved for children as young as 4 years
Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the latest print issue of Contemporary Pediatrics